Case Report
Subacute combined degeneration of the spinal cord despite prophylactic vitamin B12 treatment

https://doi.org/10.1016/j.jocn.2011.08.028Get rights and content

Abstract

We describe a 35 year-old man presenting with a four-week history of non-painful limb paraesthesias and unsteady gait causing falls. On examination he had an ataxic gait associated with dorsal column sensory loss. He had a medical history of a partial gastrectomy six years prior and anaemia. He had received monthly intramuscular hydroxycobalamin injections since the gastrectomy. Laboratory tests revealed normal vitamin B12 and holotranscobalamin levels, a reduced serum caeruloplasmin of 0.05 g/L (normal: 0.22–0.58 g/L), a copper-to-caeruloplasmin ratio of 1.9 μmol/L (11.0–22.0 μmol/L) and a reduced 24-hour urinary copper concentration of <0.30 μmol/L (0–0.3 μmol/L). Cerebrospinal fluid analysis, nerve conduction studies, electromyography and visual-evoked responses were unremarkable. MRI revealed abnormal hyperintense signal in the cervical dorsal columns. Hypocupric myelopathy was diagnosed and he was treated with daily oral elemental copper. Three months later, his walking and balance had improved although there was no change noted on MRI.

Section snippets

Case report

A 35-year-old man presented with a four-week history of non-painful paraesthesias in both his hands and feet, and an unsteady gait associated with falls, especially in the dark. There was a history of a partial gastrectomy six years ago for a refractory bleeding duodenal ulcer. Since then he had received monthly intramuscular hydroxycobalamin and oral iron replacement for iron deficiency anaemia. There was no family history of neurological disease and no history of intentional zinc

Discussion

This patient presented with a clinicoradiological picture of SCD of the spinal cord despite B12 replacement over years and repeatedly normal vitamin B12 levels. The cause was hypocupricemia producing hypocupric myelopathy, also known as copper deficiency myelopathy. To our knowledge, this is the first documented patient in Australia.

Hypocupric myelopathy was first reported in 20011 and has been increasingly recognised as a cause of myelopathy virtually indistinguishable from SCD due to B12

Acknowledgement

We would like to thank Dr Raouf Bassily for his help with organising malabsorption studies.

References (19)

  • V. Desai et al.

    Role of copper in human neurological disorders

    Am J Clin Nutr

    (2008)
  • R. Uauy et al.

    Essentiality of copper in humans

    Am J Clin Nutr

    (1998)
  • N. Kumar

    Copper deficiency myelopathy (human swayback)

    Mayo Clin Proc

    (2006)
  • B. Schleper et al.

    Copper deficiency-associated myelopathy in a 46-year-old woman

    J Neurol

    (2001)
  • R.T. Naismith et al.

    Acute and bilateral blindness due to optic neuropathy associated with copper deficiency

    Arch Neurol

    (2009)
  • B.P. Goodman et al.

    Clinical and electrodiagnostic findings in copper deficiency myeloneuropathy

    J Neurol Neurosurg Psychiatry

    (2009)
  • N. Kumar et al.

    Copper deficiency myelopathy

    Arch Neurol

    (2004)
  • T.R. Halfdanarson et al.

    Hematological manifestations of copper deficiency: a retrospective review

    Eur J Haematol

    (2008)
  • N. Kumar et al.

    Myelopathy due to copper deficiency following gastrointestinal surgery

    Arch Neurol

    (2003)
There are more references available in the full text version of this article.

Cited by (0)

View full text